DSC ADVISORS L P
Q4 2021 Form 13-F

CHICAGO, ILLINOIS
CIK 0001299434 · CRD 158312 · SEC-registered investment adviser
Consolidated report · includes 1 manager since Q2 2017
$129.4M Reported Value Total
SEC Registered Discretionary Manager
Private funds (Form ADV)
6 funds · $483.9M gross asset value
Hedge Fund: $483.9M
Source: Form ADV filed 2020-02-14
Reported value
$129.4M
Quarter over quarter
+8.3%
Holdings
68
Top-10 concentration
72.2%

Filing Structure

Reports holdings for

  • DSCQG PR LLC (not a 13F filer in our records) · Q4 2016 – Q1 2017 · declared by one filing
  • DACQG PR LLC (not a 13F filer in our records) · Q3 2016 – Q3 2016 · declared by one filing
  • DSC Quantitative Group, LLC (not a 13F filer in our records) · Q2 2013 – Q2 2016 · declared by one filing

Key People

Form ADV owners & control persons
Andrew Gordon Bluhm
PRINCIPAL
Amy Catherine Close
CHIEF COMPLIANCE OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2021 13F record

Q4 2021 13F filing summary

Q4 2021 Form 13F portfolio summary
Period of report December 31, 2021
Filed February 14, 2022
Form 13F-HR
Reported value $129.4M
Positions 68
Change in reported value +31.4%
New positions 9
Exited positions 9
Position turnover 23.4%
Top-10 concentration 72.2%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2024 13F
Filed Nov 14, 2024
19 $11.0M
Q2 2024 13F
Filed Aug 14, 2024
23 $30.0M
Q1 2024 13F
Filed May 15, 2024
30 $62.6M
Q4 2023 13F
Filed Feb 14, 2024
26 $60.5M
Q3 2023 13F
Filed Nov 14, 2023
26 $77.9M
Q2 2023 13F
Filed Aug 14, 2023
25 $66.7M
Q1 2023 13F
Filed May 15, 2023
19 $114.5M
Q4 2022 13F
Filed Feb 14, 2023
15 $43.5M
Q3 2022 13F
Filed Nov 14, 2022
93 $97.0M
Q2 2022 13F
Filed Aug 15, 2022
109 $100.1M
Q1 2022 13F
Filed May 16, 2022
127 $290.3M
Q4 2021 13F
Filed Feb 14, 2022
68 $129.4M
Q3 2021 13F
Filed Nov 15, 2021
68 $98.5M
Q2 2021 13F
Filed Aug 16, 2021
65 $138.4M
Q1 2021 13F
Filed May 14, 2021
75 $161.4M
Q4 2020 13F
Filed Feb 16, 2021
40 $120.9M
Q3 2020 13F
Filed Nov 16, 2020
39 $149.5M
Q2 2020 13F
Filed Aug 14, 2020
29 $91.2M
Q1 2020 13F
Filed May 15, 2020
28 $102.4M
Q4 2019 13F
Filed Feb 14, 2020
79 $208.7M

26 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q4 2021

Largest Q4 2021 13F positions by reported value
# Holding Reported value % of portfolio
1 QQQ P INVESCO QQQ TR $39.8M 30.74%
2 CVS CVS HEALTH CORP $11.3M 8.76%
3 COR AMERISOURCEBERGEN CORP $8.6M 6.67%
4 GOOG ALPHABET INC $6.7M 5.14%
5 BMRN BIOMARIN PHARMACEUTICAL INC $6.2M 4.78%
6 ATH ATHENE HOLDING LTD $5.3M 4.09%
7 ZBH ZIMMER BIOMET HOLDINGS INC $5.2M 3.98%
8 GBT GLOBAL BLOOD THERAPEUTICS IN $4.7M 3.62%
9 BMRN P BIOMARIN PHARMACEUTICAL INC $3.1M 2.39%
10 VYNE VYNE THERAPEUTICS INC $2.6M 2.01%
11 GOOGL ALPHABET INC $2.0M 1.54%
12 MSFT MICROSOFT CORP $2.0M 1.54%
13 AAPL APPLE INC $1.8M 1.42%
14 META META PLATFORMS INC $1.8M 1.36%
15 AMZN AMAZON COM INC $1.5M 1.13%
16 BRK-B BERKSHIRE HATHAWAY INC DEL $1.4M 1.09%
17 NVDA NVIDIA CORPORATION $1.2M 0.94%
18 EAR EARGO INC $1.2M 0.91%
19 EHTH EHEALTH INC $1.1M 0.89%
20 V VISA INC $1.1M 0.86%

Values as reported on the Q4 2021 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings